Upstream Bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| UPB | NBP | ACTI.ST | BBOT | NGEN | PRTC.L | |
|---|---|---|---|---|---|---|
| Market cap | 202.65M | 117.16M | 102.54M | 184.40M | 145.16M | 302.55M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.3 | -0.8 | — | -0.8 | -4.0 | -5.1 |
| Price/book | 0.7 | 0.6 | 2.8 | 0.6 | 4.3 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −85.86% | −76.29% | −34.67% | −81.29% | −44.30% | −2.36% |
| Today | +9.14% | 0.00% | +5.71% | −0.86% | +2.27% | −0.64% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All UPB news ›Celularity (NASDAQ:CELU) versus Upstream Bio (NASDAQ:UPB) Head-To-Head Contrast
Posted by Sarita Garza on Nov 4th, 2026 Celularity (NASDAQ:CELU – Get Free Report) and Upstream Bio (NASDAQ:UPB – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
Reviewing Upstream Bio (NASDAQ:UPB) and Keros Therapeutics (NASDAQ:KROS)
Posted by Sarita Garza on Oct 12th, 2026 Keros Therapeutics (NASDAQ:KROS – Get Free Report) and Upstream Bio (NASDAQ:UPB – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.